wuxi biologics: covid-19 antibody products out by year end
Published 4 years ago • 3.8K plays • Length 7:59Download video MP4
Download video MP3
Similar videos
-
6:21
china's wuxi biologics working on programs for covid-19 virus: ceo
-
7:46
coronavirus treatment: antibodies and the race for a vaccine
-
5:16
developing antibodies for covid-19
-
18:41
accelerated ind for covid - biologics manufacturing asia 2022
-
1:13
should you get a coronavirus antibody test?
-
3:20
vaccine production speed will be a 'global challenge': wuxi biologics
-
5:00
mixing covid-19 vaccines raises antibodies, study finds
-
0:28
podcast: the importance of evaluating developability in antibody discovery stage
-
9:05
china 'definitely' needs 2nd covid booster dose: cansino biologics ceo
-
4:43
study finds antibodies last for six months after covid infection
-
6:26
china's innovent biologics may look into m&as, cfo says
-
0:55
webinar: advanced analytical strategies
-
4:29
‘a lot of work to be done’ on covid-19 antibodies, says sauer of johns hopkins
-
0:59
largest covid vaccine study yet finds links to health conditions
-
1:05
webinar: developability assessment and optimization in antibody drug discovery
-
0:45
webinar: accelerating high-concentration protein drug product development
-
0:39
webinar: an advanced and highly flexible single b cell technology platform for antibody discovery
-
2:22
moderna vaccine produced antibodies in all patients tested